Research News   |   Drug News   |   Conference News


ALS TDI 2010 Leadership Summit
October 13, 2010
The ALS Therapy Development Institute's 2010 Leadership Summit was held on October 3rd and 4th. The gathering of researchers, patients, and families covered a variety of topics, including drugs currently in the development pipeline, the usefulness of stem cells, and new mouse models. This article in the MDA/ALS newsmagazine provides a good overview of the conference. You can also check out Prize4Life's recent blog post on the Leadership Summit here: http://blog.prize4life.org/2010/10/als-tdi-hosts-2010-leadership-summit.html.


Drug Development for Neurodegenerative Diseases Conference Part 4
August 2, 2010
This next installment of blog coverage from the Drug Development for Neurodegenerative Diseases conference organized by marcus evans focuses on the much buzzed about topic of regeneration.


Drug Development for Neurodegenerative Diseases Conference Part 3
July 26, 2010
Switching tracks, the next speaker, Dr. Gregory Stewart, Director of CNS Drug Therapy R&D for Medtronic, offered a slightly different perspective on therapeutic development in his talk entitled: Targeted Drug Delivery for Neurodegenerative Disease: A New Hope.


Drug Discovery for Neurodegenerative Diseases Part 2
July 23, 2010
We thought that there were some points worth mentioning from a presentation entitled: Translational AD Drug Discovery and Development: The Potential Role of In Vivo Multi-modal Imaging Techniques (yes, it is a mouthful), presented by Dr. Feng Luo of Abbott Laboratories.


Drug Development for Neurodegenerative Diseases Conference Part 1
May 19, 2010
Prize4Life is pleased to bring you exclusive coverage as the conference blogger for Drug Development for Neurodegenerative Diseases, a conference organized by marcus evans. With over 40 representatives from industry and academia, the conference is focused on new therapeutic developments, biomarkers, target identification, and issues in clinical trial design for neurodegenerative disease. Without further adieu we bring you the round-up from day one….